<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Lurosetron</id>
	<title>Lurosetron - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Lurosetron"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Lurosetron&amp;action=history"/>
	<updated>2026-04-21T14:23:04Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=Lurosetron&amp;diff=5369008&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Lurosetron&amp;diff=5369008&amp;oldid=prev"/>
		<updated>2024-03-06T04:43:59Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Lurosetron.png|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Lurosetron&amp;#039;&amp;#039;&amp;#039; is a [[pharmacological]] agent that is currently under investigation for its potential therapeutic applications. It is classified as a [[5-HT3 receptor antagonist]], a class of drugs that block the action of serotonin at the 5-HT3 receptor, a subtype of the [[serotonin receptor]].&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
[[Lurosetron]] acts by blocking the [[5-HT3 receptor]], a type of [[G protein-coupled receptor]] that is found in the central and peripheral nervous system. The 5-HT3 receptor is activated by the neurotransmitter [[serotonin]], and its activation is associated with a variety of physiological responses, including the regulation of mood, anxiety, and the vomiting reflex.&lt;br /&gt;
&lt;br /&gt;
By blocking the action of serotonin at the 5-HT3 receptor, lurosetron can potentially modulate these responses. This makes it a potential candidate for the treatment of conditions such as [[irritable bowel syndrome]] (IBS), [[chemotherapy-induced nausea and vomiting]] (CINV), and [[postoperative nausea and vomiting]] (PONV).&lt;br /&gt;
&lt;br /&gt;
==Clinical Trials==&lt;br /&gt;
As of now, [[lurosetron]] is still in the experimental stages and has not been approved for clinical use. It is currently being tested in [[clinical trials]] to evaluate its safety and efficacy in patients with conditions such as IBS and CINV.&lt;br /&gt;
&lt;br /&gt;
==Potential Side Effects==&lt;br /&gt;
Like all drugs, lurosetron has the potential to cause side effects. These may include headache, constipation, and dizziness. However, the exact side effect profile of lurosetron will not be known until more extensive clinical trials have been conducted.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[5-HT3 receptor antagonist]]&lt;br /&gt;
* [[Serotonin receptor]]&lt;br /&gt;
* [[Clinical trials]]&lt;br /&gt;
&lt;br /&gt;
{{Pharmacology-stub}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Experimental drugs]]&lt;br /&gt;
[[Category:5-HT3 receptor antagonists]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>